EUVIMEDEUVIMED entdecken
Crossref

Systemic disease associations and management of pyoderma gangrenosum: a single-center retrospective case series

Ilyas El Kassimi, Adil Rkiouak, Nawal Sahel, Meryem Zaizaa, Zineb El Bougrini, Bilal Talamoussa, Youssef Sekkach

European Journal of Medical Case Reports · 21.06.2026 · 10 (7) · 218-222

DOI: 10.24911/ejmcr.9-2648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Medical Case Reports, online erschienen am 19.06.2026. Verfasst von Ilyas El Kassimi und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis frequently associated with systemic inflammatory diseases. We aimed to describe systemic disease associations, management strategies, and outcomes of PG managed in internal

medicine.

Settings: Single-center retrospective case series conducted in an internal medicine department between January 2021 and December 2025.

Methods

We retrospectively reviewed all eligible patients treated for PG in our department during the study period. Diagnosis was based on clinicopathological assessment after exclusion of major mimickers; the Delphi consensus criteria were not formally applied because their individual components were not consistently documented in the retrospective records. Demographic, clinical, histological, treatment, and outcome data were extracted from medical records.

Results

Ten patients (five women; median age 40 years, range 19-58) were included. Ulcerative PG predominated (6/10), while four patients had pustular PG; lesions mainly involved the lower limbs, and pathergy was observed in five patients. An associated systemic disease was identified in eight patients, including Behçet disease, inflammatory bowel disease, systemic sclerosis, antineutrophil cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus, and Takayasu arteritis. All patients received systemic corticosteroids; additional immunosuppressants or anti-tumor necrosis factor-alpha therapy were used as steroidsparing treatment and/or to control active associated systemic disease. Six patients achieved complete healing without relapse, whereas four experienced at least one relapse during chart-documented follow-up.

Conclusion

In internal medicine practice, PG is commonly linked to systemic inflammatory diseases, supporting a structured, clinically guided systemic work-up. Systemic corticosteroids remain first-line therapy, while immunosuppressants and targeted biologics are valuable steroid-sparing options when disease is refractory or coexists with active systemic inflammation.

Zitieren

APA

Kassimi, I. E., Rkiouak, A., Sahel, N., Zaizaa, M., Bougrini, Z. E., Talamoussa, B., & Sekkach, Y. (2026). Systemic disease associations and management of pyoderma gangrenosum: a single-center retrospective case series. European Journal of Medical Case Reports, 10(7), 218-222. https://doi.org/10.24911/ejmcr.9-2648

Vancouver

Kassimi IE, Rkiouak A, Sahel N, Zaizaa M, Bougrini ZE, Talamoussa B, et al. Systemic disease associations and management of pyoderma gangrenosum: a single-center retrospective case series. European Journal of Medical Case Reports. 2026;10(7):218-222. doi:10.24911/ejmcr.9-2648

BibTeX
@article{Kassimi2026,
  author = {Kassimi, Ilyas El and Rkiouak, Adil and Sahel, Nawal and Zaizaa, Meryem and Bougrini, Zineb El and Talamoussa, Bilal and Sekkach, Youssef},
  title = {Systemic disease associations and management of pyoderma gangrenosum: a single-center retrospective case series},
  journal = {European Journal of Medical Case Reports},
  year = {2026},
  volume = {10},
  number = {7},
  pages = {218--222},
  doi = {10.24911/ejmcr.9-2648}
}
Kostenlos starten →